TFX Flex™ Joint Health Supplement Announces Plans to Aggressively Take on the Glucosamine & Chondroitin Market for Joint Pain Relief
TFX Health, LLC announced plans to take on the glucosamine & chondroitin dominated joint health market with aggressive new online promotions offering a better solution for joint pain. The new promotions scheduled to begin August 5, 2013 will feature its popular joint health supplement TFX Flex™ which contains a revolutionary new dietary ingredient that has been shown in clinical studies to be 2X more effective than glucosamine & chondroitin for joint pain relief.
Salt Lake City, UT (PRWEB) August 02, 2013
TFX Health, LLC, a leading nutritional health and wellness company headquartered in Salt Lake City, UT announced a major marketing initiative earlier this week to take on the joint health supplement market with aggressive new online promotions aimed specifically at glucosamine & chondroitin. Since its introduction more than 2 decades ago, the combination of glucosamine and chondroitin for joint support has dominated the industry, exceeding $2 Billion in annual worldwide sales making it one of the best-selling dietary supplements in history. Despite its dominance in the industry, glucosamine & chondroitin has recently come under fire from the scientific and medical community with serious questions about the efficacy of this combination as a remedy for joint pain relief.
A study published in the British Medical Journal in 2010 concluded that, “glucosamine and chondroitin, either taken together or separately, have not shown a clinically significant improvement in joint pain relief for patients troubled with knee or hip osteoarthritis [BMJ 2010; 341:c4675]. The author of the study stated that, “Our findings indicate that glucosamine, chondroitin, and their combination do not result in a relevant improvement in joint pain relief nor affect joint space narrowing compared with placebo.”
More recently in 2012, the European Food Safety Authority (EFSA) denounced joint support claims for glucosamine. The EFSA panel concluded that, “a cause and effect relationship has not been established between the consumption of glucosamine and maintenance of normal joint cartilage in individuals with osteoarthritis” [EFSA Journal 2012;10(5):2691].
A TFX Health company spokesman explained, “The science behind joint health is rapidly changing. Glucosamine & chondroitin are no longer the only options for joint pain relief and certainly not the best option. As a company, our goal is to educate the public about better alternatives and to debunk the myth that glucosamine & chondroitin is the best remedy for joint pain.”
As part of its ongoing effort to offer better solutions, TFX Health, LLC teamed up with GNC to launch TFX Flex™ a popular new joint health supplement that is expected to revolutionize the industry. Both partners understand that joints can only be as healthy as the bones and muscles to which they are attached. TFX Flex™ is the only product on the market that combines clinically proven ingredients for muscle, bone, and joint support providing a safe and effective solution for the entire musculoskeletal system. Since its introduction, TFX Flex™ has become GNC’s best-selling triple threat for bone, muscle, and joint health.
TFX Flex™ contains a breakthrough new dietary ingredient known as UC-II® that has been proven in human clinical studies to be 2X more effective than Glucosamine & Chondroitin for joint pain relief. UC-II® was developed by a team of scientists with more than 25 years of experience in the development of patented, clinically proven dietary ingredients. It holds 7 international and U.S. patents and is supported by 9 human clinical studies, including research at Harvard Medical School.
In a randomized, double-blind, placebo-controlled human clinical study published in the International Journal of Medical Science it was found that only 40 mg of UC-II® Undenatured Type II Collagen was more than two times as effective as 1,500 mg of glucosamine and 1,200 mg of chondroitin in supporting joint health, comfort and flexibility. It outperformed the glucosamine & chondroitin combination in three different joint pain relief assessment tools: WOMAC, VAS and the Lequesne Functional Index. UC-II® significantly decreased joint pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. UC-II® was also shown to be safe and well tolerated with no known side effects [Int J Med Sci. 2009; 6:312-321].
As baby boomers age, there is a greater need for safe and effective joint health solutions. TFX Health, LLC hopes to play a leadership role in introducing these solutions to the public. Its aggressive new online marketing promotions for TFX Flex™ are designed to share this message with the world.
To learn more about TFX Flex™ Joint Health Supplement please visit http://www.TFXflex.com/
About TFX Health, LLC
Based in Salt Lake City, TFX Health, LLC is an innovative pioneer in the development of advanced health and wellness products. Its brands include TFX Flex™ Joint Health Supplement, TFX Drive™ Testosterone Booster, TFX Elite™ Extreme Thermogenic, and other high end formulations. TFX Health products are manufactured in the USA in FDA registered, GMP compliant facilities and sold worldwide through online and traditional retail channels.
UC-II® is a trademark of InterHealth N.I. Clinical data available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/8/prweb10987558.htm